Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J O'Connor

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|January 2, 2025
Personalized medicine: when the common becomes the rareDaniel J O'Connor
The Lancet. Haematology|June 17, 2018
Changing views on adverse event reportingBeatriz Flores, Sigrid Klaar, Daniel J O'Connor
The Lancet. Oncology|May 5, 2018
Incorporating the patient experience into regulatory decision making in the USA, Europe, and CanadaPaul G Kluetz, Daniel J O'Connor, Katherine Soltys
Frontiers in Medicine|July 25, 2025
Editorial: The changing focus of regulatory frameworks around the globe and the opportunities for harmonizationArmando Magrelli, Daniel J O'Connor, Violeta Stoyanova-Beninska
American Journal of Ophthalmology|May 31, 2002
Additive intraocular pressure lowering effect of various medications with latanoprostDaniel J O'Connor, James F Martone, Alden Mead
Oncogene|April 13, 2004
To die or not to die: how does p53 decide?Elizabeth A Slee, Daniel J O'Connor, Xin Lu
The Lancet. Haematology|December 10, 2019
Eligibility criteria in haematological cancer clinical trials-what's needed?Mattia Calissano, Maria Beatrice Panico, Daniel J O'Connor
Nature Reviews. Drug Discovery|October 2, 2019
Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomesMelanie J Calvert, Daniel J O'Connor, Ethan M Basch
Nature Reviews. Drug Discovery|September 8, 2023
Defining rare conditions in the era of personalized medicineDaniel J O'Connor, Michela Gabaldo, Annemieke Aartsma-Rus, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 20, 2009
Making medical education more affordableArthur J Moss, Daniel J O'Connor, Leonard Pulerwitz, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|January 2, 2025
Personalized medicine: when the common becomes the rareDaniel J O'Connor
The Lancet. Haematology|June 17, 2018
Changing views on adverse event reportingBeatriz Flores, Sigrid Klaar, Daniel J O'Connor
The Lancet. Oncology|May 5, 2018
Incorporating the patient experience into regulatory decision making in the USA, Europe, and CanadaPaul G Kluetz, Daniel J O'Connor, Katherine Soltys
Frontiers in Medicine|July 25, 2025
Editorial: The changing focus of regulatory frameworks around the globe and the opportunities for harmonizationArmando Magrelli, Daniel J O'Connor, Violeta Stoyanova-Beninska
American Journal of Ophthalmology|May 31, 2002
Additive intraocular pressure lowering effect of various medications with latanoprostDaniel J O'Connor, James F Martone, Alden Mead
Oncogene|April 13, 2004
To die or not to die: how does p53 decide?Elizabeth A Slee, Daniel J O'Connor, Xin Lu
The Lancet. Haematology|December 10, 2019
Eligibility criteria in haematological cancer clinical trials-what's needed?Mattia Calissano, Maria Beatrice Panico, Daniel J O'Connor
Nature Reviews. Drug Discovery|October 2, 2019
Harnessing the patient voice in real-world evidence: the essential role of patient-reported outcomesMelanie J Calvert, Daniel J O'Connor, Ethan M Basch
Nature Reviews. Drug Discovery|September 8, 2023
Defining rare conditions in the era of personalized medicineDaniel J O'Connor, Michela Gabaldo, Annemieke Aartsma-Rus, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|January 20, 2009
Making medical education more affordableArthur J Moss, Daniel J O'Connor, Leonard Pulerwitz, et al.
Pageof 2